Fibralign Corporation

Fibralign is an award-winning, commercial-stage, Stanford-spinout that designs, develops and produces novel therapeutic medical devices to address major unmet medical needs. One of those novel devices is BioBridge®, a collagen matrix thread made with Fibralign’s patented Nanoweave® technology which is designed to enhance, control and potentiate the natural lymphangiogenesis process.